"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 3 | 3 |
| 2005 | 2 | 21 | 23 |
| 2006 | 2 | 13 | 15 |
| 2007 | 1 | 11 | 12 |
| 2008 | 1 | 23 | 24 |
| 2009 | 7 | 25 | 32 |
| 2010 | 3 | 16 | 19 |
| 2011 | 2 | 22 | 24 |
| 2012 | 4 | 24 | 28 |
| 2013 | 5 | 31 | 36 |
| 2014 | 3 | 34 | 37 |
| 2015 | 8 | 37 | 45 |
| 2016 | 2 | 40 | 42 |
| 2017 | 7 | 26 | 33 |
| 2018 | 4 | 22 | 26 |
| 2019 | 2 | 27 | 29 |
| 2020 | 1 | 25 | 26 |
| 2021 | 3 | 22 | 25 |
| 2022 | 0 | 17 | 17 |
| 2023 | 0 | 4 | 4 |
| 2024 | 3 | 7 | 10 |
| 2025 | 1 | 8 | 9 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.
-
Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters. Front Immunol. 2025; 16:1734453.
-
Mouse scalp development requires Rac1 and SRF for the maintenance of mechanoresponsive mesenchyme. Development. 2025 Nov 15; 152(22).
-
Chemogenetic Activation of Oligodendrocytes Delays Postnatal Myelination by Promoting Progenitor Proliferation and Inhibiting Maturation. Glia. 2026 Feb; 74(2):e70094.
-
A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. Sci Rep. 2025 Oct 14; 15(1):35811.
-
Differential Effect of P2X7 Receptors on Proliferation and Migration of Human Keratinocytes and Dermal Fibroblasts. Int J Mol Sci. 2025 Sep 03; 26(17).
-
CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation. Cancer Lett. 2025 Oct 01; 629:217886.
-
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteine. Proc Natl Acad Sci U S A. 2025 May 13; 122(19):e2410766122.
-
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.
-
Focal adhesion kinase (FAK): emerging target for drug-resistant malignant tumors. Mol Biol Rep. 2025 Feb 20; 52(1):248.